NCT06671808Completed
HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes
HIV Infection Accompanied by Multi-Drug Resistant Tuberculosis: a Decadal Systematic Review and Meta-Analysis
Source: ClinicalTrials.gov · Last updated 4 Nov 2024
Brief summary (registry, in English)
This study aims to investigate the relationship between HIV infection and multi-drug resistant tuberculosis (MDR-TB) among affected individuals in Zahedan, Iran. It will involve a detailed analysis of patient demographics, clinical characteristics, and treatment outcomes to enhance understanding of this co-infection. The findings may inform better treatment strategies and healthcare policies for managing these diseases in similar populations.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 222128 (actual)
- First submitted
- 1 Nov 2024
- Start date
- 15 May 2024
- Primary completion date
- 22 Aug 2024
- Lead sponsor
- Zahedan University of Medical Sciences
- Diseases
- Tuberculosis, HIV
- NCT number
- NCT06671808
What you commit to
- Study type: Observational
- Participants enrolled: 222128
- From 15 May 2024 to the primary completion date, 22 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Studies that focus solely on drug-susceptible tuberculosis without MDR-TB.
- Studies lacking sufficient data on the co-occurrence of HIV and MDR-TB.
Age
- Studies involving pediatric populations (under 18 years of age).
Other
- Non-original research such as reviews, editorials, and commentaries.
- Studies that do not adhere to ethical guidelines for human subjects or lack appropriate ethical approvals.
Who the study is looking for
- Adults (aged 18 years and older) diagnosed with both HIV and multi-drug-resistant tuberculosis (MDR-TB).
- Studies published in peer-reviewed journals.
- Studies that provide data on the co-occurrence of HIV and MDR-TB.
- Participants from diverse geographical regions to enhance generalizability.
- Studies with clear definitions of MDR-TB according to WHO guidelines.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zahedan University of Medical Sciences Coordinator of this site? Confirm its status | Zahedan | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.